Results 71 to 80 of about 3,296 (112)

Inibidores da glicoproteína IIb/IIIa na prática clínica Inhibidores de la glicoproteína IIb/IIIa en la práctica clínica Glycoprotein IIb/IIIa inhibitors in clinical practice

Arquivos Brasileiros de Cardiologia, 2009
Felipe Maia, Francisco Carleal Feijó de Sá, Fausto Feres   +2 more
doaj   +1 more source

[Prescription drug consumption recovery following the co-payment change: Evidence from a regional health service]. [PDF]

Aten Primaria, 2015
Sánchez DP, Guillén JJ, Torres AM, Arense JJ, López Á, Sánchez FI.   +5 more
europepmc   +1 more source

[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Pury S, Saranz RJ, Irastorza MJ, Sasia LV, Visconti P, Alegre G, Lozano NA, Berardi YV, Lozano A.   +8 more
europepmc   +1 more source

[Review of plasma anti-aggregants and their indications in primary care. Eight years later]. [PDF]

Aten Primaria, 2003
Blasco Valle M, Lucía Cuesta JF.
europepmc   +1 more source

¿Cómo actúan y porqué se usan los sensibilizadores de las proteínas contráctiles al Ca2+ en la insuficiencia cardiaca?: II [PDF]

Sin ...
Garcia Escobar, Judith, García Liras, Francisco Javier, Herrera Zurdo, Pablo   +2 more
core   +1 more source

[Impact of P-CABs in the Treatment of Acid-related Diseases: an Evidence Review]. [PDF]

Acta Gastroenterol Latinoam
Remes-Troche JM, Vargas-Basurto JL, Valdovinos-García L.   +2 more
europepmc   +1 more source

[Sleep disorders and environmental conditions in the elderly]. [PDF]

Aten Primaria, 2009
Gras CB, Hidalgo JL, García YD, Lapeira JT, Ferrer AV, Martínez IP.   +5 more
europepmc   +1 more source

Latin-American guidelines of recommendations at discharge from an acute coronary syndrome. [PDF]

Arch Cardiol Mex
Ponte-Negretti CI, Zaidel EJ, López-Santi R, Múnera-Echeverri AG, Bryce A, Negrón S, Espinoza J, Gaibor JC, Valcárcel Y, Antonio C, Juárez-Lloclla J, Puente-Barragán A, Ullauri-Solórzano VE, Cueva-Torres FE, Nuriulú-Escobar PL, Spina SV, Veitía HL, Alcocer-Gamba MA, Carrión-Arcela JP, Villarreal RA, Martínez-Cervantes A, Rodas-Díaz M, Domínguez-Méndez B, Wyss-Quintana FS, Piskorz DL, Pérez GE, Scatularo CE, Peñaherrera-Patiño CE, Valdez-Tiburcio O, Sosa-Liprandi MI, Burgos LM, Borrayo-Sánchez G, Acevedo-Blanco M, Costabel JP, Quintana M, Amaro-Alcalá JJ, Rivera-Pineda JA, Varleta P, Lara-Terán J, García-Saldivia MA, Ilarraza-Lomelí H, González-Carta K, González-Juanatey JR, Mendoza I, Baranchuk A, Alcocer-B L.   +45 more
europepmc   +1 more source

[Rational use of rofecoxib]. [PDF]

Aten Primaria, 2000
Alvaro-Gracia Alvaro JM, González Enríquez J, Ramírez Arrizabalaga R, Sanmartí Sala R, Villasante Claudios F, Ferré de la Peña P.   +5 more
europepmc   +1 more source